| Lipids Management |
1 |
1 |
| Statins |
0 |
0.98 |
| Clinical Guidelines |
0 |
0.14 |
| Coronary Artery Disease (CAD) |
0 |
0.12 |
| Cardiovascular Risk Management |
0 |
0.11 |
| Adverse Effects |
0 |
0.08 |
| Patient Safety |
0 |
0.08 |
| Peripheral Artery Disease |
0 |
0.06 |
| Artery |
0 |
0.05 |
| Chronic Kidney Disease |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Myocardial Infarction (MI) |
0 |
0.05 |
| Renal Failure |
0 |
0.05 |
| Renal Disease |
0 |
0.04 |
| Adherence |
0 |
0.03 |
| Cardiovascular disease |
0 |
0.03 |
| Clinical Research |
0 |
0.03 |
| Depression |
0 |
0.03 |
| Face |
0 |
0.03 |
| Generics |
0 |
0.03 |
| Grant |
0 |
0.03 |
| Healthcare and Medical Technology |
0 |
0.03 |
| Infarction |
0 |
0.03 |
| Internet |
0 |
0.03 |
| Interprofessional Continuing Education |
0 |
0.03 |
| Jobs |
0 |
0.03 |
| Kidney |
0 |
0.03 |
| LDL Cholesterol |
0 |
0.03 |
| Medical Life |
0 |
0.03 |
| Metabolism |
0 |
0.03 |
| Office Visits |
0 |
0.03 |
| Point-of-Care |
0 |
0.03 |
| Primary Care |
0 |
0.03 |
| Receptors |
0 |
0.03 |
| Social Media |
0 |
0.03 |
| Type 2 Diabetes Mellitus |
0 |
0.03 |